Biotin Anti-Human CD15 Antibody[HI98]

Introducing the BIOTIN ANTI-HUMAN CD15 ANTIBODY[HI98], a highly advanced and meticulously developed product designed to cater to the needs of the scientific community. This antibody, specifically engineered to target the CD15 antigen found on human cells, offers unparalleled precision and accuracy in various research applications.

Crafted with utmost care and expertise, the BIOTIN ANTI-HUMAN CD15 ANTIBODY[HI98] boasts exceptional specificity and sensitivity, ensuring reliable and reproducible results. Its biotin conjugation further enhances its versatility, allowing for seamless integration into a wide range of experimental protocols.

This antibody's exceptional performance is a testament to its rigorous quality control measures, ensuring batch-to-batch consistency and reliability. Its robust binding affinity to the CD15 antigen guarantees optimal detection and quantification, enabling researchers to delve deeper into the intricacies of human cell biology.

The BIOTIN ANTI-HUMAN CD15 ANTIBODY[HI98] is meticulously optimized for various applications, including flow cytometry, immunohistochemistry, and immunofluorescence. Its compatibility with multiple experimental techniques empowers researchers to explore diverse avenues of investigation, facilitating groundbreaking discoveries and advancements in the field.

Furthermore, this antibody's exceptional stability and long shelf life ensure its longevity, making it an invaluable asset for laboratories and research institutions alike. Its user-friendly nature and straightforward usage instructions make it accessible to both seasoned scientists and newcomers in the field.

In summary, the BIOTIN ANTI-HUMAN CD15 ANTIBODY[HI98] stands as a pinnacle of scientific innovation, offering unparalleled precision, reliability, and versatility. With its exceptional performance and compatibility across various applications, this antibody is poised to revolutionize human cell research and contribute to the advancement of scientific knowledge.